Journal of the American College of Radiology最新文献

{"title":"A Multicomponent Behavior Change and Implementation Strategy to Increase Lung Cancer Screening in Primary Care Practices: The IBREATHE Study","authors":"Lauren K. Groner DO, MS ,&nbsp;Katja Reuter PhD ,&nbsp;Nathalie Moise MD, MS ,&nbsp;Laura Robbins DSW ,&nbsp;Rulla Tamimi ScD ,&nbsp;Rishikesh P. Dalal MD, MPH ,&nbsp;Stephen J. Peterson MD, MACP ,&nbsp;Luis Blanco BFA ,&nbsp;Kimberly L. Murdaugh MD, MS ,&nbsp;Erica Phillips MD, MS","doi":"10.1016/j.jacr.2024.12.004","DOIUrl":"10.1016/j.jacr.2024.12.004","url":null,"abstract":"<div><h3>Objectives</h3><div>Despite broader eligibility under the 2021 US Preventive Services Task Force guidelines, national lung cancer screening (LCS) uptake remains at around 16%. This radiologist-led study sought to identify LCS barriers in primary care settings and develop a theory-based behavior change and implementation strategy to improve screening rates in these settings.</div></div><div><h3>Methods</h3><div>A multiphase approach was used, including qualitative methods and frameworks (ie, Behavior Change Wheel; Capability, Opportunity, and Motivation of Behavior model; Theoretical Domains Framework; and Expert Recommendations for Implementing Change glossary) to understand and address LCS barriers.</div></div><div><h3>Results</h3><div>LCS barriers are represented by five major themes: (1) insurance pre-authorization; (2) patients’ cognitive and psychosocial barriers; (3) provider-patient knowledge and communication barriers; (4) the culture of a busy primary care practice; and (5) the test is ordered, patients do not follow through. Barriers impact primary care providers’ capability, opportunity, and motivation to implement guideline-concordant LCS into practice. The final multicomponent strategy (LungCheck) addressing these barriers includes educational meetings and materials, an implementation blueprint, a LCS navigator, a practical pack-year calculator, and electronic health records optimization.</div></div><div><h3>Conclusions</h3><div>We provide a road map for using behavioral and implementation science to understand LCS barriers and design an evidence-based, theory-informed multicomponent strategy to improve LCS uptake. Our radiologist-driven strategy addresses LCS barriers in primary care, has the potential to increase screening rates, and can serve as a model for implementing similar preventive health initiatives in other settings. The multicomponent strategy will be evaluated in a pilot study with two primary care practice models.</div></div>","PeriodicalId":49044,"journal":{"name":"Journal of the American College of Radiology","volume":"22 3","pages":"Pages 280-290"},"PeriodicalIF":4.0,"publicationDate":"2025-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143529855","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Incidentally Detected Adrenal Nodules on Lung Cancer Screening CT","authors":"Aparna Singh MD,&nbsp;Mark M. Hammer MD,&nbsp;Suzanne C. Byrne MD","doi":"10.1016/j.jacr.2024.12.003","DOIUrl":"10.1016/j.jacr.2024.12.003","url":null,"abstract":"<div><h3>Objective</h3><div>To assess adherence to ACR recommendations for managing incidental adrenal lesions detected on lung cancer screening (LCS) CT examinations.</div></div><div><h3>Methods</h3><div>We performed a retrospective analysis of all LCS CT examinations within our health care system from January 2015 to August 2023. We included CTs that were reported with Lung-RADS “S” modifier for a focal adrenal lesion. We recorded whether follow-up imaging and biochemical testing were recommended and whether they were performed. Follow-up recommendations in reports were assessed for adherence to ACR recommendations.</div></div><div><h3>Results</h3><div>During the study period, 191 patients had a focal adrenal nodule reported. Per ACR recommendations, 36 of 191 (19%) warranted follow-up, but only 23 of 36 (64%) of these received follow-up recommendations. Of those 191, 155 (81%) did not require follow-up per ACR, and 25 of those 155 (16%) received follow-up recommendations. Of those who were advised follow-up, 34 of 48 (71%) received dedicated follow-up, 9 of 48 (19%) received follow-up imaging for another reason, and 5 of 48 (10%) did not receive any follow-up. Among those in whom follow-up was not recommended, 21 of 143 (15%) received dedicated follow-up, 101 of 143 (71%) received follow-up imaging for another reason, and 21 of 143 (15%) did not receive any follow-up. No malignant lesions were diagnosed. Per ACR recommendations, 183 of 191 (96%) of patients should have received biochemical testing; however, it was recommended in only 4 patients (2%).</div></div><div><h3>Discussion</h3><div>There was suboptimal adherence to ACR recommendations for managing incidental adrenal lesions on LCS CTs, with both unnecessary and missing follow-up recommendations. Recommendations for biochemical testing were nearly nonexistent, despite being part of the ACR algorithm.</div></div>","PeriodicalId":49044,"journal":{"name":"Journal of the American College of Radiology","volume":"22 3","pages":"Pages 291-296"},"PeriodicalIF":4.0,"publicationDate":"2025-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143529856","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Patient-Reported Barriers and Preferred Interventions to Improve Lung Cancer Screening Uptake","authors":"Jinho Jung BS ,&nbsp;Eisa Razzak BA ,&nbsp;Axs Roc Avenido BS ,&nbsp;Ali Rashidi MD ,&nbsp;Stephanie Jia BS ,&nbsp;Natalie Q. Tran BS ,&nbsp;Rachel Yao BS ,&nbsp;Emily L. Nguyen BS ,&nbsp;Arsanyous Bernaba BS ,&nbsp;Richard Echeverria MSc ,&nbsp;Tan Q. Nguyen MD ,&nbsp;Amir Imanzadeh MD ,&nbsp;Gelareh Sadigh MD","doi":"10.1016/j.jacr.2024.10.010","DOIUrl":"10.1016/j.jacr.2024.10.010","url":null,"abstract":"<div><h3>Objective</h3><div>Lung cancer screening (LCS) utilization remains low. We aimed at assessing LCS patient-reported barriers and preferred interventions to improve uptake.</div></div><div><h3>Methods</h3><div>Between July and November 2023, an electronic 60-item survey was completed by consented patients aged 50 to 80 years who were due to receive LCS, and their eligibility for LCS was confirmed. The survey assessed patients’ LCS perceptions and preferences to increase uptake. Regression analyses was performed to assess associated sociodemographic factors.</div></div><div><h3>Results</h3><div>In all, 12,558 patients were contacted; 1,396 responded, 871 were interested, and 86 were eligible and enrolled (mean age: 62.4; 40% female; 79.1% White, 4.7% Asian, 2.3% Black). LCS was perceived as beneficial for early lung cancer detection by 91.9%, yet only 24.4% had undergone LCS previously. Of the respondents, 54.7% identified barriers to LCS with the most common being cost (23.3%) and lack of symptoms (23.3%). Current (versus former) smokers reported higher barrier scores (B coefficient: 7.06, 95% confidence interval [CI], 1.71-13.12) and lower self-efficacy scores (B coefficient: −5.15; 95% CI, −8.73 to −1.56). Patients with prior cancer screening had higher self-efficacy scores (B coefficient, 8.92; 95% CI, 1.95-15.88). Preferred interventions included patient reminders (63.3%), primary care provider notification about LCS eligibility (62.0%), and educational materials (60.8%). Patients with higher self-efficacy (odds ratio, 1.16; 95% CI, 1.06-1.27) were more likely to prefer reminders. Patients with personal cancer history were more likely to prefer primary care provider notification (odds ratio, 5.81; 95% CI, 1.15,29.22).</div></div><div><h3>Conclusions</h3><div>Our results underscore the LCS perceived benefits and barriers, as well as patient-preferred interventions to enhance screening participation.</div></div>","PeriodicalId":49044,"journal":{"name":"Journal of the American College of Radiology","volume":"22 3","pages":"Pages 269-279"},"PeriodicalIF":4.0,"publicationDate":"2025-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143529854","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Bone Mineral Density and Trabecular Microarchitecture Screening in Lung Transplant Candidates","authors":"Alain E. Sherman MD, MBA ,&nbsp;Aspan M. Shokrekhuda MD ,&nbsp;Deepak P. Kalbi MD ,&nbsp;Jenny T. Bencardino MD ,&nbsp;Kwang J. Chun MD","doi":"10.1016/j.jacr.2024.12.009","DOIUrl":"10.1016/j.jacr.2024.12.009","url":null,"abstract":"<div><h3>Purpose</h3><div>Lung transplant candidates routinely undergo dual-energy x-ray absorptiometry (DXA) screening due to increased risk of osteoporosis secondary to comorbidities and prolonged immunosuppression. Nonetheless, postoperative insufficiency fractures have been well documented, even in patients with normal bone mineral density (BMD). This study investigated the added value of trabecular bone score (TBS) as a complementary screening index of bone microarchitecture.</div></div><div><h3>Methods</h3><div>A retrospective review of 143 lung transplant candidates who underwent preoperative DXA screening was performed. TBS was calculated from DXA of the lumbar spine. DXA and TBS measurements were standardized using T-scores with reference to established population-based datasets.</div></div><div><h3>Results</h3><div>Differences in the observed rates of osteopenia (36.4%), osteoporosis (11.2%), partially degraded bone (35.0%), and degraded bone (35.0%) were statistically significant (<em>P</em> &lt; .001). Abnormal trabecular microarchitecture was significantly more prevalent than abnormal BMD (69.9% versus 47.6%; <em>P</em> &lt; .001). TBS T-scores (mean = −1.98, SD = 1.39) were, on average, significantly lower than DXA T-scores (mean = −0.80, SD = 1.57; <em>t</em>[142] = 9.09; <em>P</em> &lt; .001). Hispanic patients (mean = −1.25, SD = 1.28) had significantly lower DXA T-scores compared with White (mean = −0.28, SD = 1.14) or Black patients (mean = −0.30, SD = 1.31; <em>F</em>[2, 109] = 8.28; <em>P</em> &lt; .001). By contrast, TBS T-scores did not differ by race or ethnicity (<em>F</em>[2, 109] = 0.26; <em>P</em> = .78).</div></div><div><h3>Conclusions</h3><div>Impaired trabecular microarchitecture is extremely common among lung transplant candidates, with a substantial proportion at risk of fracture through degraded bone despite normal BMD. TBS offers promise as a simple, robust, inexpensive, and noninvasive screening adjunct to DXA in this unique and vulnerable population.</div></div>","PeriodicalId":49044,"journal":{"name":"Journal of the American College of Radiology","volume":"22 3","pages":"Pages 342-348"},"PeriodicalIF":4.0,"publicationDate":"2025-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143529368","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Opportunistic Detection of Hepatocellular Carcinoma Using Noncontrast CT and Deep Learning Artificial Intelligence","authors":"Chengzhi Peng MBBS ,&nbsp;Philip Leung Ho Yu PhD ,&nbsp;Jianliang Lu MPhil ,&nbsp;Ho Ming Cheng PhD ,&nbsp;Xin-Ping Shen MD ,&nbsp;Keith Wan-Hang Chiu MD ,&nbsp;Wai-Kay Seto MD","doi":"10.1016/j.jacr.2024.12.011","DOIUrl":"10.1016/j.jacr.2024.12.011","url":null,"abstract":"<div><h3>Objective</h3><div>Hepatocellular carcinoma (HCC) poses a heavy global disease burden; early diagnosis is critical to improve outcomes. Opportunistic screening—the use of imaging data acquired for other clinical indications for disease detection—as well as the role of noncontrast CT have been poorly investigated in the context of HCC. We aimed to develop an artificial intelligence algorithm for efficient and accurate HCC detection using solely noncontrast CTs.</div></div><div><h3>Methods</h3><div>A 3-D convolutional block attention module (CABM) model was developed and trained on noncontrast multiphasic CT scans. HCC was diagnosed following American Association for the Study of Liver Disease guidelines and confirmed via 12-month clinical composite reference standard. CT observations were reviewed by radiologists; observations in at-risk patients were annotated via the Liver Imaging Reporting and Data System. Internal validation, independent external testing, and sensitivity analyses were performed to evaluate model performance and generalizability.</div></div><div><h3>Results</h3><div>In all, 2,223 patients were included. The CBAM model achieved an area under the receiver operating curve (AUC) of 0.807 (95% confidence interval [CI] 0.772-0.841) on the internal validation cohort, comparable to radiological interpretation at 0.851 (95% CI 0.820-0.882). Among at-risk patients, cases with definite HCC outcomes, indeterminate scans, and scans with small lesions &lt; 2 cm in size, the model attained AUCs of 0.769 (95% CI 0.721-0.817), 0.815 (95% CI 0.778-0.853), 0.769 (95% CI 0.704-0.834), and 0.773 (95% CI 0.692-0.854). On external testing cohort with 584 patients, the CBAM model achieved an AUC of 0.789 (95% CI 0.750-0.827).</div></div><div><h3>Discussion</h3><div>The CBAM model achieved a diagnostic accuracy comparable to radiological interpretation during internal validation. Artificial intelligence analysis of noncontrast CTs has a potential role in HCC opportunistic screening.</div></div>","PeriodicalId":49044,"journal":{"name":"Journal of the American College of Radiology","volume":"22 3","pages":"Pages 249-259"},"PeriodicalIF":4.0,"publicationDate":"2025-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143529426","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Racial and Ethnic Disparities in Screening Mammography During COVID-19 in the Upper Midwest","authors":"Nia Foster BS ,&nbsp;Arissa Milton BS ,&nbsp;Ryan W. Woods MD, MPH ,&nbsp;Mai Elezaby MD ,&nbsp;Joan Neuner MD, MPH ,&nbsp;Kelly Hackett MPH ,&nbsp;Noelle LoConte MD, MS ,&nbsp;Elizabeth S. Burnside MD, MHS, MS ,&nbsp;Anand K. Narayan MD, PhD","doi":"10.1016/j.jacr.2025.01.001","DOIUrl":"10.1016/j.jacr.2025.01.001","url":null,"abstract":"<div><h3>Objective</h3><div>Studies conducted prior to COVID-19 suggested that racial and ethnic disparities in mammographic screening have reduced over time. COVID-19 has had devastating effects on racial and ethnic minority populations, resulting in delays in preventive screening. Our purpose was to determine if racial and ethnic minority groups were less likely to receive mammographic screening during the COVID-19 pandemic.</div></div><div><h3>Methods</h3><div>Retrospective cross-sectional study was conducted in a multisite academic medical center in the Upper Midwest to evaluate screening disparities during the COVID-19 pandemic. Participants included 50- to 74-year-old female individuals (June 2021 to May 2022). Additional control group was included for pre-COVID-19 case-control comparison (June 2018 to May 2019). Unadjusted and adjusted logistic regression analyses estimated the association between screening and race and ethnicity including interaction terms to assess temporal interactions associated with COVID-19. Study was deemed exempt from institutional review board review.</div></div><div><h3>Results</h3><div>In all, 37,509 eligible female patients were included. Of them, 73.8% of eligible patients received a mammogram within the last 2 years (White 74.7%, Black 57.6%, Asian 67.0%, American Indian 60.1%, Hispanic 64.2%). In our adjusted analyses, Black (<em>P</em> &lt; .001), Asian (<em>P</em> = .003), and American Indian patients (<em>P</em> = .001) were less likely to receive screening. Hispanic patients were comparably likely to receive screening (<em>P</em> = .338). Non-English-preferred languages, uninsured or Medicaid, and living in rural areas were associated with decreased screening (<em>P</em> &lt; .001). In all, 36,768 eligible female patients were included for pre-COVID-19 comparison. Compared with the pre–COVID-19 time period, COVID-19 was associated with increased screening disparities (<em>P</em> &lt; .001) for Black and Hispanic women (<em>P</em> &lt; .001).</div></div><div><h3>Conclusion</h3><div>The COVID-19 pandemic was associated with increased racial and ethnic screening disparities. Targeted outreach efforts are required to ensure equitable access to mammographic screening for medically underserved patient populations.</div></div>","PeriodicalId":49044,"journal":{"name":"Journal of the American College of Radiology","volume":"22 3","pages":"Pages 315-323"},"PeriodicalIF":4.0,"publicationDate":"2025-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143529491","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Association of Average Cyst Diameter Versus Single Maximum Diameter of Pancreatic Cysts to Cyst Volume and Impact on Screening Guideline Classification","authors":"Sara Babapour MD ,&nbsp;Abraham F. Bezuidenhout MD ,&nbsp;Miriel Handler MD ,&nbsp;Clarissa Lee ,&nbsp;Alexander Brook PhD ,&nbsp;Leo L. Tsai MD, PhD","doi":"10.1016/j.jacr.2024.12.005","DOIUrl":"10.1016/j.jacr.2024.12.005","url":null,"abstract":"<div><h3>Objective</h3><div>To compare the association of single maximum diameter and average cyst diameter of pancreatic cysts measured on magnetic resonance cholangiopancreatography (MRCP) with segmented cyst volume and secondarily evaluate the effect of average cyst diameter on screening guideline classification.</div></div><div><h3>Methods</h3><div>Consecutive patients with pancreatic cysts &lt; 3 cm on MRCP in 2017 were retrospectively identified. The single maximum diameter and perpendicular short axis diameter of pancreatic cysts obtained on coronal MRCP were measured and their average was taken to determine average cyst diameter. Calculated volume approximations based on single maximum diameter and average cyst diameter were compared with segmented cyst volume. Subsequently, patients were classified based on average cyst diameter versus single maximum diameter according to a currently used screening guideline. Intraclass correlation was used to assess interobserver agreement. Williams’s test was used to compare between-group correlation coefficients.</div></div><div><h3>Results</h3><div>The mean value of single maximum diameters and average cyst diameter of the 86 included cysts were 15.4 ± 7.3 mm and 12.6 ± 6.1 mm, respectively. The mean volume of segmented cysts was 1,521 ± 1,983 mm³. Interreader agreement for measurement of cyst diameters was excellent (<em>r</em> = 0.99). The volume calculated based on the average cyst diameter correlated better to segmented cyst volume (<em>r</em> = 0.88) than single maximum diameter (<em>r</em> = 0.73, <em>P</em> &lt; .0001). Of 86 patients, 24 (28%) were classified to a less stringent follow-up strategy by using average cyst diameter.</div></div><div><h3>Discussion</h3><div>The average cyst diameter more accurately reflects the segmented cyst volume than a single maximum diameter. Utilization of average cyst diameter in existing screening guidelines reclassified 28% of patients into lower-risk screening groups, which would reduce subsequent surveillance imaging overall.</div></div>","PeriodicalId":49044,"journal":{"name":"Journal of the American College of Radiology","volume":"22 3","pages":"Pages 324-331"},"PeriodicalIF":4.0,"publicationDate":"2025-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143529492","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Hepatocellular Carcinoma Screening: From Current Standard of Care to Future Directions","authors":"Michael Mohnasky MBS ,&nbsp;Sandra Gad MSc ,&nbsp;Andrew Moon MD, MPH ,&nbsp;A. Sidney Barritt MD, MSCR ,&nbsp;Resmi A. Charalel MD, MPH ,&nbsp;Caroline Eckblad ,&nbsp;Andrew Caddell ,&nbsp;Minzhi Xing MD, MPH ,&nbsp;Nima Kokabi MD","doi":"10.1016/j.jacr.2024.10.014","DOIUrl":"10.1016/j.jacr.2024.10.014","url":null,"abstract":"<div><div>Hepatocellular carcinoma (HCC) represents a significant portion of global cancer incidence and mortality. Screening with ultrasound with or without alpha-fetoprotein is recommended for those at high-risk. Although screening can lead to earlier treatment and better outcomes, existing screening paradigms have several flaws. Ultrasound does not capture all early lesions and has lower efficacy in specific populations such as patients with obesity or those with metabolic dysfunction-associated steatotic liver disease (MASLD). Additionally, individuals with noncirrhotic MASLD and chronic hepatitis C also develop HCC, although not at high enough rates to justify screening based on current standards. These individuals, however, represent a substantial proportion of new HCC cases given rising MASLD rates and the endemic nature of hepatitis C in certain regions. Risk-stratifying these populations may reveal subsets that are higher risk and warrant screening. Several imaging advances, including contrast-enhanced ultrasound and abbreviated MRI protocols, may improve detection compared with the current approach. Evaluation of risk stratification and validation of these new imaging methods via clinical trials would likely lead to adjusting screening guidelines. This narrative review provides a diagnostic and interventional radiology-focused summary of the HCC screening guidelines and their recent evolution and highlights emerging imaging methods as potential screening tools of the future.</div></div>","PeriodicalId":49044,"journal":{"name":"Journal of the American College of Radiology","volume":"22 3","pages":"Pages 260-268"},"PeriodicalIF":4.0,"publicationDate":"2025-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143529543","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Using Incidental Radiologic Findings of Hepatic Steatosis to Improve the Diagnosis of Metabolic Dysfunction-Associated Steatotic Liver Disease","authors":"Emily Schonfeld MD ,&nbsp;Andrea Siobhan Kierans MD ,&nbsp;Rena Fox MD ,&nbsp;Danielle Brandman MD, MAS","doi":"10.1016/j.jacr.2024.12.014","DOIUrl":"10.1016/j.jacr.2024.12.014","url":null,"abstract":"<div><div>Metabolic dysfunction-associated steatotic liver disease (MASLD) is a common cause of liver disease worldwide. In patients with MASLD, liver fibrosis stage is the most significant predictor of mortality; therefore, early identification of patients at the greatest risk of advanced fibrosis is essential. Noninvasive tests predict advanced fibrosis and are recommended for use in primary care settings to determine which patients would benefit most from specialty care. The adoption of these tools is not widespread, and several studies have reported underrecognition of cirrhosis in patients with MASLD and diabetes. The finding of hepatic steatosis on imaging performed for evaluation of nonliver conditions may present an avenue for opportunistic screening to identify more patients with MASLD. This article will review recommendations for when hepatic steatosis is found on imaging and noninvasive tests that can be used to help predict fibrosis staging. This is a significant area of research because a new treatment for MASLD has been approved, and other treatments may follow.</div></div>","PeriodicalId":49044,"journal":{"name":"Journal of the American College of Radiology","volume":"22 3","pages":"Pages 358-365"},"PeriodicalIF":4.0,"publicationDate":"2025-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143529370","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Realizing the Potential for Opportunistic Early Detection of Abnormalities on Medical Imaging Using Artificial Intelligence","authors":"Monica M. Matsumoto MD ,&nbsp;Christoph I. Lee MD, MS, MBA","doi":"10.1016/j.jacr.2024.09.003","DOIUrl":"10.1016/j.jacr.2024.09.003","url":null,"abstract":"","PeriodicalId":49044,"journal":{"name":"Journal of the American College of Radiology","volume":"22 2","pages":"Pages 230-231"},"PeriodicalIF":4.0,"publicationDate":"2025-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142302713","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}